MAPLE GROVE, MN-Boston Scientific has told city officials in Maple Grove that it will go ahead with the construction of a 120,000 sf, $25 million new research and development building at its divisional campus there. The company, which also told the city it will add “300 to 600″ new jobs at the campus, has tentatively set the announcement for the expansion on Feb. 17, according to Al Madsen, city administrator for the city of Maple Grove.

The expansion is related to a new market that Boston Scientific expects to enter in a matter of weeks—drug-coated stents. The Natick, MA-based company is on the verge of getting approval from the federal Food and Drug Administration to sell the Taxus stent in the US. Many Wall Street analysts predict Boston Scientific could quickly dominate the market. They also expect the overall market segment could soon grow to $5 billion next year.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.